Glaucoma practice marketing: screening claims, Medicare eligibility, drop, laser and surgery claims, and emergency wording

A glaucoma page is read by a person who was told at an eye exam that their eye pressure is high and wants to know what that means, by someone whose parent lost side vision to glaucoma and wonders about their own risk, and by a patient who has used drops for years and is tired of them. The practice may be an ophthalmology group with a glaucoma specialist, an optometry office that manages glaucoma with a referral partner, or a surgery center that offers laser and surgical care. Each reader wants a plain answer about a disease that can take vision without warning, and the pages that earn their trust describe glaucoma the way the National Eye Institute does: a condition that can be found and treated, with no cure and no way to give back vision already lost. This guide covers screening claims, Medicare eligibility wording, risk group messages, claims about drops, laser and surgery, and the emergency wording every glaucoma page needs.

Six related topics have their own guides and are not repeated here. Exams, recall, eyewear and the general optometry site are covered in our guide to optometry marketing ideas. Lens upgrades, out-of-pocket charges and cataract surgery claims are covered in our guide to premium cataract lens marketing. Planning a screening table, free services for Medicare and Medicaid attendees, sign-in sheets and follow-up permission are covered in our guide to health fair and screening event marketing. Medicare plan wording, mailers and seminars are covered in our guide to marketing to Medicare patients. Surgery center pages are covered in our guide to ambulatory surgery center marketing, and specialist titles and board wording in our guide to physician bio pages and board certification.

What NEI, MedlinePlus, USPSTF and Medicare say

A glaucoma page starts with what the disease is, how it is found, who is at higher risk, what treatment can and cannot do and when eye symptoms are an emergency. The sources describe it this way:

• The NEI page Glaucoma (last updated August 19, 2026) says glaucoma is a group of eye diseases that can cause vision loss and blindness by damaging the optic nerve, that symptoms can start so slowly a person may not notice them, and that the only way to find out is a comprehensive dilated eye exam, which includes a visual field test. It says there is no cure, that early treatment can stop the damage and protect vision in a large number of cases, that treatment will not undo damage already done, and that there is no way to prevent glaucoma. It lists people over 60, Hispanic or Latino people over 60, African American people over 40 and people with a family history as being at higher risk, and says people at higher risk need a comprehensive dilated eye exam every 1 to 2 years.
• The NEI page Types of Glaucoma (last updated December 5, 2024) calls angle-closure glaucoma a medical emergency, tells people to go to the doctor or emergency room immediately if they suddenly have intense eye pain, nausea, a red eye or blurry vision, and says untreated angle-closure glaucoma can cause blindness in just a few days.
• The NEI page Glaucoma and Eye Pressure (last updated December 5, 2024) says not everyone with high eye pressure will develop glaucoma, and some people with normal eye pressure get glaucoma.
• The NEI page Glaucoma Medicines (last updated December 5, 2024) says glaucoma eye drops will not cure glaucoma or reverse vision loss but can keep it from getting worse, that a person prescribed drops needs to use them every day, and that a doctor will probably want a patient to keep using them as long as the medicine is working.
• The NEI page Laser Treatment for Glaucoma (last updated August 6, 2025) says laser treatment works very well for a majority of people but does not work for everyone, that it takes 4 to 6 weeks to find out if it worked, that the majority of people will need to keep taking glaucoma medicine after laser treatment, and that the effect wears off over time, so a person may need it more than once.
• The NEI page Glaucoma Surgery (last updated August 20, 2026) describes trabeculectomy, implant surgery and minimally invasive glaucoma surgery, says the benefits last a long time for some people while others need surgery again, says drops are prescribed after surgery for several weeks, and lists possible risks including cataract, cornea problems, eye pressure that is too low and vision loss.
• The MedlinePlus page Glaucoma (last updated January 13, 2025) says there may be no symptoms at first, that without treatment glaucoma can eventually lead to blindness, and that there is no cure but glaucoma can generally be controlled.
• The USPSTF recommendation Primary Open-Angle Glaucoma: Screening (May 24, 2022) is an I statement for asymptomatic adults 40 or older: “The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults.” It says there is insufficient evidence to recommend for or against screening in the primary care setting in persons without symptoms of vision impairment.
• The Medicare.gov page Glaucoma screenings (checked October 30, 2026) says Part B covers a glaucoma screening once every 12 months for people at high risk, meaning at least one of these applies: they have diabetes, they have a family history of glaucoma, they are African American and 50 or older, or they are Hispanic and 65 or older. It says an eye doctor who is legally allowed to do glaucoma tests in the person’s state must do or supervise the screening, and that the Part B deductible and coinsurance apply.

Two points shape the marketing. First, the agencies describe glaucoma as a quiet, lifelong condition that treatment can hold back but not reverse, so a page that promises to restore sight, end the need for drops or prevent blindness outright claims more than the sources support. Second, one form of glaucoma is an emergency: a reader who finds the page with sudden eye pain, nausea, a red eye and blurred vision needs to be told to go to a doctor or emergency room now, before any booking button.

Screening and eye exam claims

The two federal sources say different things, and a page should not blur them. NEI says the only way to find glaucoma is a comprehensive dilated eye exam and that people at higher risk need one every 1 to 2 years. The USPSTF, looking at screening in primary care for adults without symptoms, found the evidence insufficient to recommend for or against it. A practice can quote NEI on dilated exams for people at higher risk, and if it cites the USPSTF at all, it should quote the I statement as written instead of presenting it as support for screening everyone.

A quick pressure check is not the exam NEI describes. NEI says some people with high pressure never get glaucoma and some with normal pressure do, so an event or ad that offers a pressure reading as a glaucoma test misleads in both directions. Say what the check measures, that it is not a diagnosis, and how to book a full exam.

Phrases that need rewriting:

• “Free glaucoma test in 5 minutes.” A pressure reading is not a glaucoma diagnosis. Say what the check is and that a dilated exam is how NEI says glaucoma is found.
• “Normal eye pressure? No glaucoma.” NEI says people with normal pressure can have glaucoma. Remove it.
• “The Task Force says every adult over 40 needs glaucoma screening.” The USPSTF statement is an I statement. Quote it as written.

Medicare eligibility and risk group messages

Medicare coverage is a fair thing to explain, as long as the page uses the Medicare.gov eligibility list and does not stretch it. Part B covers a screening once every 12 months only for people in the listed high-risk groups, the deductible and coinsurance apply, and the screening must be done or supervised by an eye doctor legally allowed to do it in the state. “Covered by Medicare” with no conditions overstates it; “Medicare Part B covers a glaucoma screening once every 12 months for people at high risk, as Medicare.gov defines it” says it correctly, followed by the list and a note that costs apply.

Both NEI and Medicare name racial and ethnic groups among those at higher risk. A page can quote those lists in the agencies’ own words so readers can see whether they apply. Ads are a different matter: targeting or naming people by race or ethnicity raises fairness and platform issues, so keep ad targeting to place, age ranges the platform allows and search terms, and let the page carry the agency wording.

Phrases that need rewriting:

• “Medicare pays for your yearly glaucoma test.” Coverage depends on the high-risk list and cost-sharing applies. Quote Medicare.gov.
• “Diabetic? Your glaucoma screening is free.” Diabetes is on the Medicare list, but the deductible and coinsurance still apply. State the costs plainly.

Claims about drops, laser and surgery

Treatment pages are where glaucoma copy drifts furthest from the sources. NEI says drops can keep glaucoma from getting worse but will not cure it or reverse vision loss, and that drops are used every day for as long as they work. It says laser treatment works very well for a majority of people but not for everyone, that the majority still need drops afterward and that the effect wears off. It says surgery benefits last a long time for some people while others need another operation, and it lists real risks, including vision loss. A page that promises a drop-free life, a one-time fix or restored sight contradicts every one of those statements.

Describe each option in NEI terms, say who decides which is right for a patient, and list the risks NEI lists near the claims rather than in a footnote. Newer surgical approaches can be described in the words NEI uses: for mild glaucoma, a doctor may recommend minimally invasive glaucoma surgery, which NEI says has fewer risks and side effects and helps a person recover faster. Do not name devices, implants or medicines in ads; describe a device only in the words its maker uses for its FDA status, and keep drug names off marketing pages.

Phrases that need rewriting:

• “Drop-free forever after one laser treatment.” NEI says the majority of people still need drops after laser and the effect wears off. Remove it.
• “Restore your vision with glaucoma surgery.” NEI says treatment will not undo damage. Say what surgery aims to do: lower eye pressure.
• “Painless, risk-free glaucoma surgery.” NEI lists side effects and risks. Name them.
• “Our patients never lose vision.” An outcome claim about the practice’s own results. It needs substantiation, a stated method and period, and a statement of what people can generally expect, or it comes out.

Cure, prevention and blindness claims

Fear of blindness is what brings a reader to the page, and it is tempting to answer it with a promise. NEI says there is no cure and no way to prevent glaucoma, and that treatment cannot undo damage. What the sources do support is that early treatment can stop the damage and protect vision in a large number of cases, and that without treatment glaucoma can eventually cause blindness. That is a strong message on its own: find it early, keep up with treatment, keep follow-up visits.

Supplements, diets and eye vitamins marketed for glaucoma fall under the same advertising rules as any health claim, set out below, and the practice that sells them carries the claim. Keep such products off the glaucoma page; our guide to selling supplements in a medical practice covers the FDA wording.

Phrases that need rewriting:

• “Prevent blindness with our glaucoma program.” NEI says there is no way to prevent glaucoma. Say early treatment can stop damage and protect vision in a large number of cases, as NEI does.
• “Cure your glaucoma.” NEI and MedlinePlus say there is no cure. Remove it.
• “Natural eye drops that lower eye pressure.” A treatment claim for a product. Remove it.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. A glaucoma page that implies sight will come back, or that one treatment ends the need for drops, makes that kind of claim even if the word “cure” never appears.

Emergency wording for sudden eye symptoms

Put the NEI angle-closure wording on the glaucoma page, near the top and above the booking button: if you suddenly have intense eye pain, nausea, a red eye or blurry vision, go to your doctor or an emergency room now. Add the general line “If you think you are having a medical emergency, call 911.” Link the NEI page so the reader can check the source.

The same lines belong on voicemail, after-hours messages, chat tools and text replies. An AI front desk or chat widget must not judge eye symptoms or offer a next-week slot to someone describing sudden pain and blurred vision; it should give the NEI wording and the 911 line at once and alert staff. A same-week booking prompt for a reader with those symptoms puts the schedule ahead of their sight.

Phrases that need rewriting:

• “Eye pain? Book online for our next opening.” Put the NEI emergency wording first and the booking link after it.
• “Message us about any eye symptoms.” Say who reads messages and when, that they are not watched around the clock, and give the NEI wording and 911.

Adherence and recall messages

NEI says drops are used every day and that some people stop using them after a while, and it tells patients to keep regular check-ups. Recall and refill reminders are a real service for a glaucoma practice. Under 45 CFR 164.501, a reminder about the practice’s own treatment for an individual, such as a pressure check or a visual field test due, can fall outside the definition of marketing, while a message that promotes a third party’s product generally needs a signed authorization under 45 CFR 164.508. Keep reminder text neutral, so a message a family member sees does not name the condition, and ask the patient how they want to be contacted.

Readers with reduced vision need a site they can use. Text that scales, strong contrast, buttons that work with a screen reader and phone numbers as tap-to-call links matter on a page whose readers may have lost side vision; our guide to website accessibility covers the standards. NEI suggests that people having trouble with everyday activities because of vision loss ask about vision rehabilitation, and a page can point to that service if the practice offers or refers for it.

Screening events and partners

A glaucoma table at a senior center, diabetes class or health fair can reach people who have never had a dilated exam. Our health fair guide covers planning, free services, sign-in sheets and follow-up. For glaucoma in particular, say that a pressure check or photo is not the comprehensive dilated exam NEI describes, hand each person a card with the NEI higher-risk list and how to book a full exam, and print the angle-closure warning on the card. Follow 16 CFR 251.1 for “free” offers. Diabetes programs are natural partners; see our guides to diabetes education program marketing and endocrinology practice marketing.

Glaucoma care moves between optometrists, ophthalmologists, primary care and surgery centers. Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Rules on referral fees are also set state by state. Our guide to patient and physician referrals covers the general rules.

For a glaucoma practice, keep these points:

• Do not give gifts, meals, free services or payments to referring optometrists, physicians, senior centers or diabetes programs in return for patients without counsel’s review.
• Money, staff time, event funds or equipment from a drug, device or laser company go to counsel before any agreement is signed.
• Co-management arrangements between optometrists and surgeons are reviewed by counsel, and patients are told who provides which part of care.
• Event invitations say who is paying for the event.
• Practices that see Medicaid patients follow the rules in our guide to marketing to Medicaid patients.

Privacy, pixels and ads

A visit to a glaucoma page, a booking for a pressure check or an event sign-up says something about a person’s health. Keep bookings, intake answers, test results and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place and by search terms, and should not be built from a list of patients with glaucoma or high eye pressure.

Patient stories

A patient who describes finding glaucoma at a routine exam, or learning to put in drops each night, can move a reader who has put off an exam. It is still one person’s experience. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. “After laser I threw away my drops” is a results claim and invites readers to stop theirs. Keep the story to the experience of being diagnosed and treated, and pair it with the NEI wording that treatment cannot undo damage and that the majority of people still use drops after laser.

Get a signed authorization under 45 CFR 164.508 where the practice is a covered entity, and consent for any photo or video. Name no drug or device, say if the patient received anything for taking part, and let the patient review the final version. Our guide to testimonials and before and after photos covers the full rules.

Illustration: two glaucoma pages

Illustration: a page reads “Prevent blindness and say goodbye to eye drops. Our advanced laser cures glaucoma in one painless visit. Free glaucoma test, covered by Medicare for everyone over 40. Eye pain? Book online for next week.” It promises a cure and a drop-free life, contradicts NEI on prevention and laser, misstates Medicare eligibility and puts a booking button where the emergency wording belongs.

Illustration: a second page for the same practice reads “If you suddenly have intense eye pain, nausea, a red eye or blurry vision, go to your doctor or an emergency room now. Glaucoma generally has no symptoms at first, NEI says, and a comprehensive dilated eye exam is the way to find it. There is no cure, but early treatment can stop the damage and protect vision in a large number of cases. Medicare Part B covers a glaucoma screening once every 12 months for people at high risk as Medicare.gov defines it; costs apply. At [Practice name], [Clinician name, license] explains drops, laser and surgery, with the risks of each. Call [phone], [days and hours].” It uses the agencies’ wording, puts the emergency line first and promises nothing it cannot show.

Checklist before a glaucoma campaign goes live

• NEI wording on what glaucoma is, how it is found and who is at higher risk, named and dated.
• USPSTF I statement quoted as written if cited at all; no claim that the Task Force recommends screening everyone.
• Pressure checks described as checks, not glaucoma tests, with a path to a dilated exam.
• Medicare eligibility quoted from Medicare.gov, with the high-risk list and a note that costs apply.
• NEI angle-closure emergency wording and the 911 line above any booking button, on event cards and in chat and voicemail.
• No cure, prevention, restored-sight or drop-free claims; laser and surgery described with NEI’s limits and risks.
• No drug, device or laser brands in ads; device wording follows the maker’s FDA status.
• Risk groups quoted on the page in agency words; ad targeting kept to place and search terms.
• Free checks say what they cover and follow 16 CFR 251.1.
• No gifts or payments to referral sources, co-management reviewed, and no maker funding without counsel’s review.
• Bookings and results stay out of pixels and ad audiences; reminder text does not name the condition.
• Stories have signed authorizations, name no product, leave out stopping drops and carry a statement of what people can generally expect.

Glaucoma care shares patients with retina care. Macular degeneration, diabetic eye exams, injection treatment and supplement and stem cell claims are covered in our guide to retina practice marketing.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including eye care practices that diagnose and treat glaucoma. For a glaucoma practice, that means a site that quotes NEI and Medicare.gov as written, puts the emergency wording above the booking button and reads well for patients with reduced vision, plus booking and event forms that keep test results and diagnoses off the web and away from tracking tools. Our front desk tools hand eye emergency messages to the NEI wording and the 911 line and do not triage symptoms. We do not decide who needs treatment; your clinicians do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• NEI: Glaucoma (last updated August 19, 2026)
• NEI: Types of Glaucoma (last updated December 5, 2024)
• NEI: Glaucoma and Eye Pressure (last updated December 5, 2024)
• NEI: Glaucoma Medicines (last updated December 5, 2024)
• NEI: Laser Treatment for Glaucoma (last updated August 6, 2025)
• NEI: Glaucoma Surgery (last updated August 20, 2026)
• MedlinePlus: Glaucoma (last updated January 13, 2025)
• USPSTF: Primary Open-Angle Glaucoma: Screening (May 24, 2022)
• Medicare.gov: Glaucoma screenings (checked October 30, 2026)
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 251.1: Guide concerning use of the word free and similar representations
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 45 CFR 164.501: Definitions
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing